Kineta
is a Washington-based biotechnology company that researches and develops novel immunotherapies for the treatment of cancer... Read moreKineta
is a Washington-based biotechnology company that researches and develops novel immunotherapies for the treatment of cancer... Read more
2008
PublicAcquired by TuHura Biosciences, Inc.NASDAQKA
News
Jun 30, 2025
PR Newswire
Press Release: Kineta : TuHURA Biosciences Completes Acquisition of Kineta
Jun 24, 2025
Citybizlist
Kineta: TuHURA Biosciences And Kineta Stockholders Approve Proposed Merger
Mar 07, 2025
Owler
Kineta, Inc.: Kineta's employee count changed from 11 in Dec 2023 to 4 in Dec 2024
Feb 06, 2025
Global Legal Chronicle
Kineta: TuHURA Biosciences' Acquisition of Kineta
Dec 12, 2024
PR Newswire
Press Release: Kineta : SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Kineta, Inc. - KANT
Dec 12, 2024
Citybizlist
Kineta: TuHURA Biosciences to Acquire Kineta
Nov 08, 2024
centralcharts
Press Release: Kineta : Kineta Updates KVA12123 Clinical Results from Ongoing Phase 1/2 VISTA101 Study at Society for Immunotherapy of Cancer (2024)
Nov 06, 2024
Marketscreener
Kineta: Kineta, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
Sep 19, 2024
StreetInsider
Press Release: Kineta : Kineta, Inc Transitioning from Nasdaq to OTC Markets
Aug 20, 2024
Clinical Trials Arena
Kineta: After 5 months of financial woes, Kineta restarts recruitment in Phase I/II trial
